On Friday, Revolution Medicines Inc (NASDAQ: RVMD) opened lower -5.94% from the last session, before settling in for the closing price of $44.42. Price fluctuations for RVMD have ranged from $25.93 to $62.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -23.15% annually for the last half of the decade. Company’s average yearly earnings per share was noted 9.92% at the time writing. With a float of $151.66 million, this company’s outstanding shares have now reached $167.75 million.
In an organization with 378 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -17912.67%, operating margin of -88031.94%, and the pretax margin is -76377.09%.
Revolution Medicines Inc (RVMD) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Revolution Medicines Inc is 16.83%, while institutional ownership is 81.78%. The most recent insider transaction that took place on Dec 16 ’24, was worth 196,553. In this transaction Chief Operating Officer of this company sold 4,329 shares at a rate of $45.40, taking the stock ownership to the 127,991 shares. Before that another transaction happened on Dec 16 ’24, when Company’s insider sold 11,714 for $45.40, making the entire transaction worth $531,860. This insider now owns 325,056 shares in total.
Revolution Medicines Inc (RVMD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 9.92% per share during the next fiscal year.
Revolution Medicines Inc (NASDAQ: RVMD) Trading Performance Indicators
Check out the current performance indicators for Revolution Medicines Inc (RVMD). In the past quarter, the stock posted a quick ratio of 14.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 10295.38.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.59, a number that is poised to hit -0.99 in the next quarter and is forecasted to reach -3.96 in one year’s time.
Technical Analysis of Revolution Medicines Inc (RVMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.12 million. That was better than the volume of 1.06 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 43.04%. Additionally, its Average True Range was 1.72.
During the past 100 days, Revolution Medicines Inc’s (RVMD) raw stochastic average was set at 4.54%, which indicates a significant decrease from 12.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.15% in the past 14 days, which was lower than the 43.80% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $50.55, while its 200-day Moving Average is $43.64. However, in the short run, Revolution Medicines Inc’s stock first resistance to watch stands at $43.27. Second resistance stands at $44.76. The third major resistance level sits at $45.79. If the price goes on to break the first support level at $40.75, it is likely to go to the next support level at $39.72. Assuming the price breaks the second support level, the third support level stands at $38.23.
Revolution Medicines Inc (NASDAQ: RVMD) Key Stats
There are currently 168,219K shares outstanding in the company with a market cap of 7.62 billion. Presently, the company’s annual sales total 11,580 K according to its annual income of -436,370 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -156,290 K.
